These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 31219890)

  • 1. Transforming lives and empowering communities: evidence, harm reduction and a holistic approach to people who use drugs.
    Southwell M; Shelly S; MacDonald V; Verster A; Maher L
    Curr Opin HIV AIDS; 2019 Sep; 14(5):409-414. PubMed ID: 31219890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.
    Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; ; Comiskey C; Rossi C; Griffiths P
    Harm Reduct J; 2017 Apr; 14(1):19. PubMed ID: 28431584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
    Bridge J; Hunter BM; Albers E; Cook C; Guarinieri M; Lazarus JV; MacAllister J; McLean S; Wolfe D
    Int J Drug Policy; 2016 Jan; 27():132-7. PubMed ID: 26342275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "We don't need services. We have no problems": exploring the experiences of young people who inject drugs in accessing harm reduction services.
    Krug A; Hildebrand M; Sun N
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19442. PubMed ID: 25724510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peer driven or driven peers? A rapid review of peer involvement of people who use drugs in HIV and harm reduction services in low- and middle-income countries.
    Chang J; Shelly S; Busz M; Stoicescu C; Iryawan AR; Madybaeva D; de Boer Y; Guise A
    Harm Reduct J; 2021 Feb; 18(1):15. PubMed ID: 33536033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
    Aaraj E; Jreij Abou Chrouch M
    Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scale-up of a comprehensive harm reduction programme for people injecting opioids: lessons from north-eastern India.
    Lalmuanpuii M; Biangtung L; Mishra RK; Reeve MJ; Tzudier S; Singh AL; Sinate R; Sgaier SK
    Bull World Health Organ; 2013 Apr; 91(4):306-12. PubMed ID: 23599555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining barriers to creating an enabling environment in Cambodia: results from a baseline study with key populations and police.
    Schneiders ML; Weissman A
    J Int AIDS Soc; 2016; 19(4 Suppl 3):20878. PubMed ID: 27435713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Global State of Harm Reduction in Prisons.
    Sander G; Shirley-Beavan S; Stone K
    J Correct Health Care; 2019 Apr; 25(2):105-120. PubMed ID: 31084277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of harm reduction on HIV and illicit drug use.
    Ti L; Kerr T
    Harm Reduct J; 2014 Feb; 11():7. PubMed ID: 24559062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key harm reduction interventions and their impact on the reduction of risky behavior and HIV incidence among people who inject drugs in low-income and middle-income countries.
    Dutta A; Wirtz AL; Baral S; Beyrer C; Cleghorn FR
    Curr Opin HIV AIDS; 2012 Jul; 7(4):362-8. PubMed ID: 22647588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach.
    Noyes E; Yeo E; Yerton M; Plakas I; Keyes S; Obando A; Gaeta JM; Taveras EM; Chatterjee A
    Public Health Rep; 2021 May; 136(3):301-308. PubMed ID: 33673755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anova Health Institute's harm reduction initiatives for people who use drugs.
    Hugo JM; Rebe KB; Tsouroulis E; Manion A; de Swart G; Struthers H; McIntyre JA
    Sex Health; 2018 Apr; 15(2):176-178. PubMed ID: 29559070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The war on drugs is a war on us: young people who use drugs and the fight for harm reduction in the Global South.
    Stowe MJ; Gatonye R; Maharjan I; Kehinde S; Arya S; Valderrábano JH; Mcbride A; Scheibein F; Igonya EK; Fast D
    Harm Reduct J; 2024 Feb; 21(1):43. PubMed ID: 38368391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries.
    Petersen Z; Myers B; van Hout MC; Plüddemann A; Parry C
    Harm Reduct J; 2013 Aug; 10():13. PubMed ID: 23957896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population estimation and harm reduction among people who inject drugs in Addis Ababa, Ethiopia.
    Deyessa N; Senbete B; Abdo A; Mundia BM
    Harm Reduct J; 2020 Sep; 17(1):61. PubMed ID: 32894153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Fund investments in harm reduction from 2002 to 2009.
    Bridge J; Hunter BM; Atun R; Lazarus JV
    Int J Drug Policy; 2012 Jul; 23(4):279-85. PubMed ID: 22421551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
    Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
    Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
    Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
    Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.